Search research articles
Contact Us
Filters
Showing results (71-80 of 112) with videos related to
Page
of 12
Sort By:
Journal of Medicinal Chemistry
|
December 30, 2010
Synthesis and molecular modeling of novel tetrahydro-β-carboline derivatives with phosphodiesterase 5 inhibitory and anticancer properties
Heba A Mohamed, Nancy M R Girgis, Rainer Wilcken, et al.
Journal of Biomolecular Screening
|
February 22, 2011
A high-throughput screen with isogenic PTEN+/+ and PTEN-/- cells identifies CID1340132 as a novel compound that induces apoptosis in PTEN and PIK3CA mutant human cancer cells
Hui-Fang Li, Adam Keeton, Michele Vitolo, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
December 10, 2015
Mining ZINC Database to Discover Potential Phosphodiesterase 9 Inhibitors Using Structure-Based Drug Design Approach
Engi A Hassaan, Sara C Sigler, Tamer M Ibrahim, et al.
European Journal of Medicinal Chemistry
|
November 3, 2012
Exploring the PDE5 H-pocket by ensemble docking and structure-based design and synthesis of novel β-carboline derivatives
Nermin S Ahmed, Amal H Ali, Shreen M El-Nashar, et al.
Medcomm
|
October 19, 2020
Enhancing anticancer activity of checkpoint immunotherapy by targeting RAS
Antonio B Ward, Adam B Keeton, Xi Chen, et al.
Bioorganic & Medicinal Chemistry
|
October 22, 2013
Trisubstituted and tetrasubstituted pyrazolines as a novel class of cell-growth inhibitors in tumor cells with wild type p53
Mohammad Abdel-Halim, Adam B Keeton, Evrim Gurpinar, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
April 26, 2012
CoMFA and CoMSIA studies of 1,2-dihydropyridine derivatives as anticancer agents
Ismail Salama, Mohamed A O Abdel-Fattah, Marwa S Hany, et al.
Bioorganic Chemistry
|
March 22, 2020
Extending the use of tadalafil scaffold: Development of novel selective phosphodiesterase 5 inhibitors and histone deacetylase inhibitors
Ahmed K ElHady, Shou-Ping Shih, Yu-Cheng Chen, et al.
Bioorganic Chemistry
|
November 4, 2020
Discovery of trisubstituted pyrazolines as a novel scaffold for the development of selective phosphodiesterase 5 inhibitors
Mohammad Abdel-Halim, Heather Tinsley, Adam B Keeton, et al.
European Journal of Medicinal Chemistry
|
December 2, 2025
Exploring dual inhibitors Carbonic Anhydrases and Phosphodiesterase 5 as potential agents for treatment Alzheimer's disease
Alessia Costa, Gustavo Provensi, Costanza Titi, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 112) with videos related to
Sort By:
Page
of 12
Journal of Medicinal Chemistry
|
December 30, 2010
Synthesis and molecular modeling of novel tetrahydro-β-carboline derivatives with phosphodiesterase 5 inhibitory and anticancer properties
Heba A Mohamed, Nancy M R Girgis, Rainer Wilcken, et al.
Journal of Biomolecular Screening
|
February 22, 2011
A high-throughput screen with isogenic PTEN+/+ and PTEN-/- cells identifies CID1340132 as a novel compound that induces apoptosis in PTEN and PIK3CA mutant human cancer cells
Hui-Fang Li, Adam Keeton, Michele Vitolo, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
December 10, 2015
Mining ZINC Database to Discover Potential Phosphodiesterase 9 Inhibitors Using Structure-Based Drug Design Approach
Engi A Hassaan, Sara C Sigler, Tamer M Ibrahim, et al.
European Journal of Medicinal Chemistry
|
November 3, 2012
Exploring the PDE5 H-pocket by ensemble docking and structure-based design and synthesis of novel β-carboline derivatives
Nermin S Ahmed, Amal H Ali, Shreen M El-Nashar, et al.
Medcomm
|
October 19, 2020
Enhancing anticancer activity of checkpoint immunotherapy by targeting RAS
Antonio B Ward, Adam B Keeton, Xi Chen, et al.
Bioorganic & Medicinal Chemistry
|
October 22, 2013
Trisubstituted and tetrasubstituted pyrazolines as a novel class of cell-growth inhibitors in tumor cells with wild type p53
Mohammad Abdel-Halim, Adam B Keeton, Evrim Gurpinar, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))
|
April 26, 2012
CoMFA and CoMSIA studies of 1,2-dihydropyridine derivatives as anticancer agents
Ismail Salama, Mohamed A O Abdel-Fattah, Marwa S Hany, et al.
Bioorganic Chemistry
|
March 22, 2020
Extending the use of tadalafil scaffold: Development of novel selective phosphodiesterase 5 inhibitors and histone deacetylase inhibitors
Ahmed K ElHady, Shou-Ping Shih, Yu-Cheng Chen, et al.
Bioorganic Chemistry
|
November 4, 2020
Discovery of trisubstituted pyrazolines as a novel scaffold for the development of selective phosphodiesterase 5 inhibitors
Mohammad Abdel-Halim, Heather Tinsley, Adam B Keeton, et al.
European Journal of Medicinal Chemistry
|
December 2, 2025
Exploring dual inhibitors Carbonic Anhydrases and Phosphodiesterase 5 as potential agents for treatment Alzheimer's disease
Alessia Costa, Gustavo Provensi, Costanza Titi, et al.
Page
of 12